Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
Matching Placebo for selinexor Phase 3 Results Expected
Matching placebo for selinexor • Endometrial Cancer
Target Indication
Endometrial Cancer
Clinical Trial
Last updated: 12/4/2025
KPTI
Karyopharm Therapeutics Inc.
